ABBOTT LAB 20/30ABBOTT LAB 20/30ABBOTT LAB 20/30

ABBOTT LAB 20/30

No trades
See on Supercharts

US2824BQ2 analysis



Key facts


Issue date
Jun 24, 2020
Maturity date
Jun 30, 2030
Outstanding amount
‪650.00 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
1.40% (Fixed)
Yield to maturity
4.86%
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.